American Brain Tumor Association’s Team Breakthrough Crosses the Finish Line

Share Article

Runners raise record-breaking $135,000 to advance the understanding and treatment of brain tumors

News Image

Team Breakthrough, the American Brain Tumor Association’s endurance program, had 72 runners cross the finish line of the Bank of America Chicago Marathon on Sunday, October 7, 2012. In total, ABTA runners raised more than $135,000 in conjunction with Sunday’s event – a record for the ABTA in its seven years of participating in the race.

The top three Team Breakthrough fundraisers at the Chicago Marathon were Scott Badskey of Tower Lakes, IL, Oren Sagher of Ann Arbor, MI and Gelsey Steinbrecher of New York City.

“We’re so thankful to all of these amazing athletes for not only challenging themselves by competing in this world-class marathon, but for truly going the extra mile by raising funds in support of this important cause,” says ABTA President and CEO Elizabeth M. Wilson. “All of this year’s participants have been touched in some way by a brain tumor diagnosis. And each one of them is an inspiration as well as an example of what true champions are able to achieve.”

Team Breakthrough is the national endurance program for the American Brain Tumor Association, and includes half marathons, full marathons and triathlons across the country. For more information, call the ABTA’s Event Line at 800-886-1281 or email events(at)abta(dot)org.

Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit organization dedicated solely to funding brain tumor research. For nearly 40 years, the ABTA has provided critical funding to researchers working toward breakthroughs in brain tumor diagnosis, treatment and care, and is the only national organization providing comprehensive resources that support the complex needs of brain tumor patients and caregivers. For more information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Garett Auriemma
Email >
Visit website